drugset / Trial / NCT04705142

Beneficial Effect of Intravenous Magnesium Sulphate in Term Neonates With Hypoxic Ischemic Encephalopathy(HIE)

NCT04705142

Phase 2 Completed 200 enrolled Services Institute of Medical Sciences, Pakistan
NaSingle-groupOpen-labelTreatment

Summary

Neonatal mortality rate is the highest in Pakistan. And Birth Asphyxia is one of the main reversible causes. Outcomes related to birth asphyxia can be improved, if intervention done in time with proper measures. MgSO4 is cheaper and easily available drug.

Timeline

Start
2019-05-01
Primary completion
2020-12-30
Completion
2020-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 250 mg/kg Intravenous

Indications